Comparison of Combination Plasmapheresis/IVIg/Anti-CD20 Versus High-Dose IVIg in the Treatment of Antibody-Mediated Rejection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of Combination Plasmapheresis/IVIg/Anti-CD20 Versus High-Dose IVIg in the Treatment of Antibody-Mediated Rejection

Published:2009-05 Issue:5 Volume:9 Page:1099-1107
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:

Author:

Lefaucheur C.,Nochy D.,Andrade J.,Verine J.,Gautreau C.,Charron D.,Hill G. S.,Glotz D.,Suberbielle-Boissel C.

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-6143.2009.02591.x/fullpdf

Reference29 articles.

1. Antibody-mediated rejection in renal allografts: Lessons from pathology;Racusen;Clin J Am Soc Nephrol,2006

2. The spectrum of antibody-mediated renal allograft injury: Implications for treatment;Gloor;Am J Transplant,2008

3. Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection;Racusen;Am J Transplant,2003

4. National conference to assess antibody-mediated rejection in solid organ transplantation;Takemoto;Am J Transplant,2004

5. Capillary deposition of C4d complement fragment and early renal graft loss;Feucht;Kidney Int,1993

Cited by 243 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Alloantibodies on Clinical VCA Outcomes and the Need for Immune Tolerance;Transplantology;2024-07-29

2. Apheresis Indications in the Perioperative Setting;Current Anesthesiology Reports;2024-06-15

3. Higher Donor Age and Severe Microvascular Inflammation Are Risk Factors for Chronic Rejection After Treatment of Active Antibody-Mediated Rejection;Transplant International;2024-02-02

4. Interferon-γ and its response are determinants of antibody-mediated rejection and clinical outcomes in patients after renal transplantation;Genes & Immunity;2024-01-22

5. A bibliometric and knowledge-map analysis of antibody-mediated rejection in kidney transplantation;Renal Failure;2023-09-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3